TEICONOVA 400 MG
TEICONOVA 400 MG
TEICONOVA 400 MG
TEICONOVA 400 MG
TEICONOVA 400 MG
TEICONOVA 400 MG

TEICONOVA 400 MG

Price 400 INR/ Vial

MOQ : 50 Vials

TEICONOVA 400 MG Specification

  • Drug Type
  • Injection
  • Physical Form
  • Liquid
  • Recommended For
  • Doctor
  • Dosage Guidelines
  • As per Instructions
  • Storage Instructions
  • Cool & Dry Place
  • Strength
  • 40mg
  • Molecule
  • Teicoplanin Injection
 

TEICONOVA 400 MG Trade Information

  • Minimum Order Quantity
  • 50 Vials
  • Supply Ability
  • 1000 Vials Per Month
  • Delivery Time
  • 7 Days
 

About TEICONOVA 400 MG

BRAND : TEICONOVA 400 MG
CONTENT : TEICOPLANIN INJECTION 400 MG 
COMPANY : BDR PHARMACEUTICALS


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Injectables Category

TROYHEP 25000 IU / 5 ml

TROYHEP 25000 IU / 5 ml

Price 65000.0 INR / Vial

Minimum Order Quantity : 50 Vials

Storage Instructions : Store below 25C away from light and moisture

Dosage Guidelines : Use as directed by physician typically administered via injection

Recommended For : Patients with thromboembolic disorders deep vein thrombosis or pulmonary embolism

Ingredients : Heparin Sodium 25000 IU

BUPITROY HEAVY

BUPITROY HEAVY

Price 19.31 INR / Vial

Minimum Order Quantity : 100 Vials

Storage Instructions : Store in a cool dry place away from direct sunlight; keep out of reach of children

Dosage Guidelines : Administered under the supervision of a qualified healthcare provider; dosage varies based on procedure and patient profile

Recommended For : Patients requiring prolonged local anesthesia

Ingredients : Bupivacaine Hydrochloride

FOSFOFAST INJ 4G

FOSFOFAST INJ 4G

Price 605.0 INR / Vial

Minimum Order Quantity : 50 Pieces

Storage Instructions : Cool & Dry Place

Dosage Guidelines : As per Instructions

Recommended For : Doctor

Ingredients : Product Name: FOSFOFAST 4 Injection Brand: FOSFOFAST 4 Content / Active Ingredient: Fosfomycin Sodium Injection Strength: 4 g per vial Company / Manufacturer: BDR Pharmaceutical Pack Size: 4 g Vial (Dry Powder for Injection) Product Description FOSFOFAST 4 Injection is a sterile injectable antibiotic formulation containing Fosfomycin Sodium 4 g, a broadspectrum bactericidal agent used in the treatment of serious bacterial infections. It is supplied as a dry powder for reconstitution and is intended for intravenous administration under the supervision of a qualified healthcare professional. Fosfomycin Sodium works by inhibiting bacterial cell wall synthesis at an early stage, making it effective against a wide range of Grampositive and Gramnegative organisms, including certain multidrugresistant strains. It is commonly used in hospital settings for moderate to severe infections. Key Features Composition: Fosfomycin Sodium 4 g per vial Therapeutic Category: Antibiotic Phosphonic acid derivative Dosage Form: Sterile dry powder for IV injection/infusion Route of Administration: Intravenous (IV) use only Prescription Status: Schedule H Prescription medicine Packaging: 4 g single vial pack Storage: Store in a cool, dry place below recommended temperature Indications / Uses FOSFOFAST 4 Injection is indicated for the treatment of: Severe urinary tract infections Respiratory tract infections Intraabdominal infections Septicemia (bloodstream infections) Bone and joint infections Infections caused by multidrugresistant organisms Dosage and duration should be determined by a qualified healthcare professional based on infection severity and patient condition. How It Works Fosfomycin inhibits the initial step of bacterial cell wall synthesis by blocking the formation of peptidoglycan, leading to bacterial cell death. Important Notes To be administered only by trained healthcare professionals. Monitor renal function and electrolyte levels during prolonged therapy. Possible side effects include nausea, diarrhea, headache, rash, and injectionsite reactions.

BDCOLIST 1MIU

BDCOLIST 1MIU

Price 97.2 INR / Vial

Minimum Order Quantity : 50 Pieces

Storage Instructions : Cool & Dry Place

Dosage Guidelines : As per Instructions

Recommended For : Doctor

Ingredients : Product Name: BD Colist 1 MIU Injection Brand: BDCOLIST 1 MIU Vial Active Ingredient / Content: Colistimethate Sodium Injection (1 Million IU) Manufacturer / Company: BDR Pharmaceuticals Product Description BDCOLIST 1 MIU Vial is a sterile injectable antibiotic formulation containing Colistimethate Sodium, supplied as a single dose vial of 1 Million International Units (IU). It is indicated for the treatment of serious bacterial infections, especially those due to susceptible Gram negative organisms where other antibiotics are inadequate or ineffective. The product must be used only on the prescription of a qualified healthcare professional and is typically administered by intravenous infusion under clinical supervision. Key Features Composition: Colistimethate Sodium 1 MIU per vial (antibacterial agent) Form: Injectable solution after reconstitution; parenteral use only. Packaging: Single vial packaging. Storage: Store in a cool and dry place as directed by the manufacturer. Prescription Status: Schedule H prescription drug must be dispensed and administered only on medical prescription. Typical Uses (General to Colistimethate Injections) (This reflects standard clinical use for colistimethate sodium injections and is similar across branded products.) Treatment of severe hospital acquired or ventilator associated infections due to Gram negative bacteria when other antibiotics are ineffective. Management of complicated urinary tract infections, bloodstream infections, and pneumonia caused by multidrug resistant strains. Administered under hospital supervision with appropriate dosing and monitoring. Important Notes Colistimethate Sodium is a polymyxin class antibiotic that works by disrupting the bacterial cell membrane, leading to bacterial cell death. Dosing and duration of therapy must be determined by a clinician based on infection severity and patient factors. Use may require monitoring for possible kidney related side effects and other adverse reactions in susceptible patients.



Back to top